Citation: Ping Wang, Yue Wang, Ping Li, Chen Chen, Siman Ma, Linxuan Zhao, Haibing He, Tian Yin, Yu Zhang, Xing Tang, Jingxin Gou. Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities[J]. Chinese Chemical Letters, ;2023, 34(4): 107691. doi: 10.1016/j.cclet.2022.07.034 shu

Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities

Ping Wang ^{a, b} ,
Yue Wang ^{a, b} ,
Ping Li ^b ,
Chen Chen ^b ,
Siman Ma ^a ,
Linxuan Zhao ^b ,
Haibing He ^a ,
Tian Yin ^c ,
Yu Zhang ^a ,
Xing Tang ^a ,
Jingxin Gou ^{a, *,}

a.
Department of Pharmaceutics, Shenyang Pharmaceutical University, Shenyang 110016, China
b.
School of Pharmacy, Jilin University, Changchun 130021, China
c.
School of Functional Food and Wine, Shenyang Pharmaceutical University, Shenyang 110016, China

jxgou_syphu@163.com

Received Date: 14 January 2022
Revised Date: 14 July 2022
Accepted Date: 15 July 2022
Available Online: 19 July 2022

Figures(6)

Efficient oral delivery of drugs treating brain diseases has long been a challenging topic faced by the drug delivery community. Fortunately, polyester nanoparticles offer certain solutions to this problem. This review article firstly describes the main obstacles faced by oral administered brain targeting, including: (1) instability in the gastrointestinal tract; (2) poor penetration of the intestinal mucosa and epithelium; (3) blood clearance; and (4) restriction by the BBB. Then the key factors influencing brain-targeting efficiency of orally administered polyester nanoparticles are also discussed, such as size, shape and surface properties. Finally, recent brain-targeting delivery strategies using oral polyester nanoparticles as carriers and their effects on brain drugs transport are reviewed, and the delivery 'as a whole' strategy of polyester nanoparticles will provide new insight for oral brain-targeting delivery. And by combination of multiple strategies, both the stability and permeability of polyester nanoparticles can be greatly improved for oral brain drug delivery.
- Polyester nanoparticles,
- Oral brain drugs,
- Brain-targeted delivery,
- Physiological barrier,
- Absorption enhancement
1. [1]
  X. Tan, X. Liu, Y. Zhang, et al., Expert Opin. Drug Deliv. 15 (2018) 805–820. doi: 10.1080/17425247.2018.1503250
2. [2]
  N. Aggarwal, Z. Qamar, S. Rehman, S. Baboota, J. Ali, Curr. Pharm. Des. 26 (2020) 2280–2290. doi: 10.2174/1381612826666200406072451
3. [3]
  S. Yu, X. Xu, J. Feng, M. Liu, K. Hu, Int. J. Pharm. 560 (2019) 282–293. doi: 10.1016/j.ijpharm.2019.02.012
4. [4]
  F. Erdo, L.A. Bors, D. Farkas, A. Bajza, S. Gizurarson, Brain Res. Bull. 143 (2018) 155–170. doi: 10.1016/j.brainresbull.2018.10.009
5. [5]
  M.M. Wen, N.S. El-Salamouni, W.M. El-Refaie, et al., J. Control. Release 245 (2017) 95–107. doi: 10.1016/j.jconrel.2016.11.025
6. [6]
  S. Xiong, W. Liu, D. Li, et al., Mol. Pharm. 16 (2019) 1444–1455. doi: 10.1021/acs.molpharmaceut.8b01012
7. [7]
  C. Chen, L. Wang, F. Cao, et al., Int. J. Pharm. 497 (2016) 239–247. doi: 10.1016/j.ijpharm.2015.12.014
8. [8]
  T. Chen, C. Li, Y. Li, et al., Mol. Pharm. 13 (2016) 3864–3875. doi: 10.1021/acs.molpharmaceut.6b00644
9. [9]
  C.F. Luo, M. Yuan, M.S. Chen, et al., Int. J. Pharm. 410 (2011) 138–144. doi: 10.1016/j.ijpharm.2011.02.064
10. [10]
  V. Kakkar, S.K. Muppu, K. Chopra, I.P. Kaur, Eur. J. Pharm. Biopharm. 85 (2013) 339–345. doi: 10.1016/j.ejpb.2013.02.005
11. [11]
  P. Mohammadi, R. Mahjub, M. Mohammadi, et al., Drug. Dev. Ind. Pharm. 47 (2021) 146–152. doi: 10.1080/03639045.2020.1862172
12. [12]
  E. Sanchez-Lopez, M. Ettcheto, M.A. Egea, et al., J. Nanobiotechnol. 16 (2018) 32. doi: 10.1186/s12951-018-0356-z
13. [13]
  A. Mukherjee, S. Sarkar, S. Jana, S. Swarnakar, N. Das, Brain Res. 1704 (2019) 164–173. doi: 10.1016/j.brainres.2018.10.016
14. [14]
  A. Cano, M. Ettcheto, J.H. Chang, et al., J. Control. Release 301 (2019) 62–75. doi: 10.1016/j.jconrel.2019.03.010
15. [15]
  F.Q. Hu, Y. Hong, H. Yuan, Int. J. Pharm. 273 (2004) 29–35. doi: 10.1016/j.ijpharm.2003.12.016
16. [16]
  I. Posadas, S. Monteagudo, V. Cena, Nanomedicine 11 (2016) 833–849. doi: 10.2217/nnm.16.15
17. [17]
  T.M. Allen, P.R. Cullis, Science 303 (2004) 1818–1822. doi: 10.1126/science.1095833
18. [18]
  S. Kalepu, V. Nekkanti, Acta Pharm. Sin. B 5 (2015) 442–453. doi: 10.1016/j.apsb.2015.07.003
19. [19]
  T. Wang, D. Zhang, D. Sun, J. Gu, J. Pharm. Anal. 10 (2020) 221–232. doi: 10.1016/j.jpha.2020.05.002
20. [20]
  C. Fernandes, C. Martins, A. Fonseca, et al., ACS Appl. Mater. Interfaces 10 (2018) 39557–39569. doi: 10.1021/acsami.8b17224
21. [21]
  T. Chen, C.W. Li, Y. Li, et al., ACS Appl. Mater. Interfaces 9 (2017) 9516–9527. doi: 10.1021/acsami.7b01171
22. [22]
  A. Paul, S. Das, J. Das, A. Samadder, A.R. Khuda-Bukhsh, Toxicol. Lett. 222 (2013) 10–22. doi: 10.1016/j.toxlet.2013.07.006
23. [23]
  S. Ghosh, I. Ghosh, M. Chakrabarti, A. Mukherjee, Food Chem. Toxicol. 136 (2020) 110989. doi: 10.1016/j.fct.2019.110989
24. [24]
  G. Mittal, H. Carswell, R. Brett, S. Currie, M.N.V.R. Kumar, J. Control. Release 150 (2011) 220–228. doi: 10.1016/j.jconrel.2010.11.013
25. [25]
  P. Saini, R. Ganugula, M. Arora, M.N.V.R. Kumar, Sci. Rep. 6 (2016) 29501. doi: 10.1038/srep29501
26. [26]
  H.Y. Zhang, C.K. Firempong, Y.W. Wang, et al., Acta Pharmacol. Sin. 37 (2016) 834–844. doi: 10.1038/aps.2016.37
27. [27]
  T.K. Chen, W. Liu, S. Xiong, et al., ACS Appl. Mater. Interfaces 11 (2019) 45276–45289. doi: 10.1021/acsami.9b16047
28. [28]
  N. Ahmad, M.A. Alam, R. Ahmad, S. Umar, F. Jalees Ahmad, J. Microencapsul. 35 (2018) 327–343. doi: 10.1080/02652048.2018.1485755
29. [29]
  E. Sanchez-Lopez, M. Ettcheto, M.A. Egea, et al., Nanomedicine 13 (2017) 1171–1182. doi: 10.1016/j.nano.2016.12.003
30. [30]
  C. Dende, J. Meena, P. Nagarajan, et al., Sci. Rep. 7 (2017) 10062. doi: 10.1038/s41598-017-10672-9
31. [31]
  H. Shen, X.Y. Hu, M. Szymusiak, Z.J. Wang, Y. Liu, Mol. Pharmaceut. 10 (2013) 4546–4551. doi: 10.1021/mp400358z
32. [32]
  R. Pandey, G.K. Khuller, J. Antimicrob. Chemoth. 57 (2006) 1146–1152. doi: 10.1093/jac/dkl128
33. [33]
  K.V. Krishna, G. Wadhwa, A. Alexander, et al., ACS Chem. Neurosci. 10 (2019) 4124–4135. doi: 10.1021/acschemneuro.9b00343
34. [34]
  Y. Zhao, S. Xiong, P. Liu, et al., Int. J. Nanomed. 15 (2020) 10453–10467. doi: 10.2147/IJN.S272831
35. [35]
  A. Lalatsa, N.L. Garrett, T. Ferrarelli, et al., Mol. Pharmaceut. 9 (2012) 1764–1774. doi: 10.1021/mp300068j
36. [36]
  A. Lalatsa, V. Lee, J.P. Malkinson, et al., Mol. Pharmaceut. 9 (2012) 1665–1680. doi: 10.1021/mp300009u
37. [37]
  E.M. Pridgen, F. Alexis, O.C. Farokhzad, Expert Opin. Drug Del. iv 12 (2015) 1459–1473. doi: 10.1517/17425247.2015.1018175
38. [38]
  L.B. Wu, J. Zhang, W. Watanabe, Adv. Drug Deliv. Rev. 63 (2011) 456–469. doi: 10.1016/j.addr.2011.02.001
39. [39]
  C. Li, T.T. Bei, Z.H. Niu, et al., Curr. Microbiol. 76 (2019) 896–903. doi: 10.1007/s00284-019-01706-8
40. [40]
  S.H. Bakhru, S. Furtado, A.P. Morello, E. Mathiowitz, Adv. Drug Deliv. Rev. 65 (2013) 811–821. doi: 10.1016/j.addr.2013.04.006
41. [41]
  J. Griesser, G. Hetenyi, H. Kadas, et al., Int. J. Pharmaceut. 538 (2018) 159–166. doi: 10.1016/j.ijpharm.2018.01.018
42. [42]
  M. Boegh, H.M. Nielsen, Basic Clin. Pharmacol. 116 (2015) 179–186. doi: 10.1111/bcpt.12342
43. [43]
  M.C. Chen, K. Sonaje, K.J. Chen, H.W. Sung, Biomaterials 32 (2011) 9826–9838. doi: 10.1016/j.biomaterials.2011.08.087
44. [44]
  D.I.A. Pereira, N.I. Mohammed, O. Ofordile, et al., Gates Open Res. 2 (2018) 48. doi: 10.12688/gatesopenres.12866.2
45. [45]
  K.S. Kim, K. Suzuki, H. Cho, Y.S. Youn, Y.H. Bae, ACS Nano 12 (2018) 8893–8900. doi: 10.1021/acsnano.8b04315
46. [46]
  Y. Wang, X. Tan, X. Fan, et al., Expert Opin. Drug Deliv. (2021) 1–18.
47. [47]
  H. Fasehee, G. Zarrinrad, S.M. Tavangar, S.H. Ghaffari, S. Faghihi, Mater. Sci. Eng. C: Mater. Biol. Appl. 63 (2016) 587–595. doi: 10.1016/j.msec.2016.03.023
48. [48]
  V.H. Nguyen, B.J. Lee, Int. J. Nanomed. 12 (2017) 3137–3151. doi: 10.2147/IJN.S129300
49. [49]
  J.Y. Oh, H.S. Kim, L. Palanikumar, et al., Nat. Commun. 9 (2018) 4548. doi: 10.1038/s41467-018-06979-4
50. [50]
  X.W. Dong, Theranostics 8 (2018) 1481–1493. doi: 10.7150/thno.21254
51. [51]
  C. Saraiva, C. Praca, R. Ferreira, et al., J. Control. Release 235 (2016) 34–47. doi: 10.1016/j.jconrel.2016.05.044
52. [52]
  G. Tosi, L. Costantino, B. Ruozi, F. Forni, M.A. Vandelli, Expert Opin. Drug Del. 5 (2008) 155–174. doi: 10.1517/17425247.5.2.155
53. [53]
  R.G. Thorne, C. Nicholson, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5567–5572. doi: 10.1073/pnas.0509425103
54. [54]
  S.W.L. Lee, M. Campisi, T. Osaki, et al., Adv. Healthc. Mater. 9 (2020) 1901486. doi: 10.1002/adhm.201901486
55. [55]
  G. Tosi, J.T. Duskey, J. Kreuter, Expert Opin. Drug Del. 17 (2020) 23–32. doi: 10.1080/17425247.2020.1698544
56. [56]
  N. Voigt, P. Henrich-Noack, S. Kockentiedt, et al., Eur. J. Pharm. Biopharm. 87 (2014) 19–29. doi: 10.1016/j.ejpb.2014.02.013
57. [57]
  Z. Xu, D. Wang, Y. Cheng, M. Yang, L.P. Wu, Mater. Sci. Eng. C: Mater. Biol. Appl. 92 (2018) 1006–1015. doi: 10.1016/j.msec.2018.05.031
58. [58]
  M. McKenzie, D. Betts, A. Suh, et al., Molecules 20 (2015) 20397–20408. doi: 10.3390/molecules201119705
59. [59]
  E. Niza, A. Ocana, J.A. Castro-Osma, I. Bravo, C. Alonso-Moreno, Cancers 13 (2021) 3387. doi: 10.3390/cancers13143387
60. [60]
  F. Molavi, M. Barzegar-Jalali, H. Hamishehkar, J. Control. Release 320 (2020) 265–282. doi: 10.1016/j.jconrel.2020.01.028
61. [61]
  P.R. Rauta, N.M. Das, D. Nayak, S. Ashe, B. Nayak, IET Nanobiotechnol. 10 (2016) 254–261. doi: 10.1049/iet-nbt.2015.0021
62. [62]
  M. Duran-Lobato, L. Martin-Banderas, L.M.D. Goncalves, M. Fernandez-Arevalo, A.J. Almeida, J. Nanopart. Res. 17 (2015) 61. doi: 10.1007/s11051-015-2875-y
63. [63]
  I.M. Kalogeras, Eur. J. Pharm. Sci. 42 (2011) 470–483. doi: 10.1016/j.ejps.2011.02.003
64. [64]
  B. Eshaghi, N. Alsharif, X. An, et al., Adv. Sci. 7 (2020) 2000649. doi: 10.1002/advs.202000649
65. [65]
  G.J. Zhang, J.F. Zhang, Drug Des. Dev. Ther. 12 (2018) 2509–2518. doi: 10.2147/DDDT.S172919
66. [66]
  Y. Zhou, Z. Peng, E.S. Seven, R.M. Leblanc, J. Control. Release 270 (2018) 290–303. doi: 10.1016/j.jconrel.2017.12.015
67. [67]
  M. Silva-Abreu, A.C. Calpena, P. Andres-Benito, et al., Int. J. Nanomed. 13 (2018) 5577–5590. doi: 10.2147/IJN.S171490
68. [68]
  G. Mittal, D.K. Sahana, V. Bhardwaj, M.N.V.R. Kumar, J. Control. Release 119 (2007) 77–85. doi: 10.1016/j.jconrel.2007.01.016
69. [69]
  M.L. Hans, A.M. Lowman, Curr. Opin. Solid. State Mater. 6 (2002) 319–327. doi: 10.1016/S1359-0286(02)00117-1
70. [70]
  J. Hadar, S. Skidmore, J. Garner, et al., J. Control. Release 304 (2019) 75–89. doi: 10.1016/j.jconrel.2019.04.039
71. [71]
  A. Mante, M. Heider, C. Zlomke, K. Mader, Eur. J. Pharm. Biopharm. 108 (2016) 32–40. doi: 10.1016/j.ejpb.2016.08.009
72. [72]
  Y.C. Wang, Y. Zheng, L. Zhang, Q.W. Wang, D.R. Zhang, J. Control. Release 172 (2013) 1126–1141. doi: 10.1016/j.jconrel.2013.08.006
73. [73]
  H. ShamsiJazeyi, C.A. Miller, M.S. Wong, J.M. Tour, R. Verduzco, J. Appl. Polym. Sci. 131 (2014) 40576.
74. [74]
  X.H. Tian, X.N. Lin, F. Wei, et al., Int. J. Nanomed. 6 (2011) 445–452.
75. [75]
  M. Bagad, Z.A. Khan, Int. J. Nanomed. 10 (2015) 3921–3935.
76. [76]
  C. Bouissou, J.J. Rouse, R. Price, C.F. van der Walle, Pharm. Res. 23 (2006) 1295–1305. doi: 10.1007/s11095-006-0180-2
77. [77]
  M. Filippousi, M. Angelakeris, M. Katsikini, et al., J. Phys. Chem. C 118 (2014) 16209–16217. doi: 10.1021/jp5037266
78. [78]
  R. Gossmann, K. Langer, D. Mulac, PloS One 10 (2015) e0127532. doi: 10.1371/journal.pone.0127532
79. [79]
  M.A. Farooq, X.Y. Huang, A. Jabeen, et al., Colloids Surf. B 199 (2021) 111523. doi: 10.1016/j.colsurfb.2020.111523
80. [80]
  M.R. Vijayakumar, K.Y. Vajanthri, C.K. Balavigneswaran, et al., Colloids Surf. B 145 (2016) 479–491. doi: 10.1016/j.colsurfb.2016.05.037
81. [81]
  C. Curtis, D. Toghani, B. Wong, E. Nance, Colloids Surf. B 170 (2018) 673–682. doi: 10.1016/j.colsurfb.2018.06.050
82. [82]
  L.B. Wu, S.R.P. da Rocha, Langmuir 23 (2007) 12104–12110. doi: 10.1021/la702108x
83. [83]
  H.S. He, Y. Lu, J.P. Qi, et al., Acta Pharm. Sin. B 9 (2019) 36–48. doi: 10.1016/j.apsb.2018.06.005
84. [84]
  J. Witten, T. Samad, K. Ribbeck, Curr. Opin. Biotech. 52 (2018) 124–133. doi: 10.1016/j.copbio.2018.03.010
85. [85]
  M. Liu, J. Zhang, W. Shan, Y. Huang, Asian J. Pharm. Sci. 10 (2015) 275–282. doi: 10.1016/j.ajps.2014.12.007
86. [86]
  X. Zhou, Y. Liu, Y.M. Huang, et al., J. Drug Deliv. Sci. Technol 52 (2019) 157–164. doi: 10.1016/j.jddst.2019.04.030
87. [87]
  B. Semete, L. Booysen, L. Kalombo, et al., Int. J. Pharm. 424 (2012) 115–120. doi: 10.1016/j.ijpharm.2011.12.043
88. [88]
  L. Mahlert, J. Anderski, D. Mulac, K. Langer, Eur. J. Pharm. Sci. 133 (2019) 28–39. doi: 10.1016/j.ejps.2019.03.010
89. [89]
  M. Yang, S.K. Lai, Y.Y. Wang, et al., Angew. Chem. Int. Ed. 50 (2011) 2597–2600. doi: 10.1002/anie.201006849
90. [90]
  Y.Y. Wang, S.K. Lai, J.S. Suk, et al., Angew. Chem. Int. Ed. 47 (2008) 9726–9729. doi: 10.1002/anie.200803526
91. [91]
  Q. Xu, L.M. Ensign, N.J. Boylan, et al., ACS Nano 9 (2015) 9217–9227. doi: 10.1021/acsnano.5b03876
92. [92]
  Z. Zhang, J. Qi, Y. Lu, W. Wu, H. Yuan, Med. Res. Rev. 41 (2021) 2590–2598. doi: 10.1002/med.21797
93. [93]
  Y. Tang, S. Wu, J. Lin, et al., Nano Lett. 18 (2018) 6207–6213. doi: 10.1021/acs.nanolett.8b02229
94. [94]
  Y. Yin, D. Chen, M. Qiao, X. Wei, H. Hu, J. Control. Release 123 (2007) 27–38. doi: 10.1016/j.jconrel.2007.06.024
95. [95]
  J. Ding, Y. Sun, J. Li, H. Wang, S. Mao, J. Drug Target. 25 (2017) 532–540. doi: 10.1080/1061186X.2017.1289541
96. [96]
  X. Zhang, W. Wu, Drug Discov. Today 19 (2014) 898–904. doi: 10.1016/j.drudis.2014.03.001
97. [97]
  K. Thanki, R.P. Gangwal, A.T. Sangamwar, S. Jain, J. Control. Release 170 (2013) 15–40. doi: 10.1016/j.jconrel.2013.04.020
98. [98]
  C. Wang, P.C. Ho, L.Y. Lim, Int. J. Pharm. 400 (2010) 201–210. doi: 10.1016/j.ijpharm.2010.08.023
99. [99]
  L. Zhang, Y. Shi, Y. Song, et al., J. Drug Target. 26 (2018) 931–940. doi: 10.1080/1061186X.2018.1455839
100. [100]
  E.M. Pridgen, F. Alexis, T.T. Kuo, et al., Sci. Transl. Med. 5 (2013) 213ra167.
101. [101]
  M. Garinot, V. Fievez, V. Pourcelle, et al., J. Control. Release 120 (2007) 195–204. doi: 10.1016/j.jconrel.2007.04.021
102. [102]
  A.B. Shreya, S.Y. Raut, R.S. Managuli, N. Udupa, S. Mutalik, AAPS PharmSciTech 20 (2018) 15.
103. [103]
  M. Agrawal, D.K. Tripathi Ajazuddin, et al., J. Control. Release 260 (2017) 61–77. doi: 10.1016/j.jconrel.2017.05.019
104. [104]
  Y. Liu, Y. Chen, L. Lin, H. Li, Int. J. Nanomed. 15 (2020) 10385–10399. doi: 10.2147/IJN.S277645
105. [105]
  R. Ganugula, M. Arora, P. Saini, M. Guada, M. Kumar, J. Am. Chem. Soc. 139 (2017) 7203–7216. doi: 10.1021/jacs.6b13231
106. [106]
  M. Arora, R. Ganugula, N. Kuma, et al., ACS Appl. Bio Mater. 2 (2019) 3540–3550. doi: 10.1021/acsabm.9b00419
107. [107]
  H. Su, Y. Wang, S. Liu, et al., Acta Pharm. Sin. B 9 (2019) 49–58. doi: 10.1016/j.apsb.2018.10.005
108. [108]
  A. Jain, S.K. Jain, Acta Diabetol. 52 (2015) 663–676. doi: 10.1007/s00592-015-0714-3
109. [109]
  S.S. Feng, L. Mei, P. Anitha, C.W. Gan, W. Zhou, Biomaterials 30 (2009) 3297–3306. doi: 10.1016/j.biomaterials.2009.02.045
110. [110]
  L. Kou, Q. Yao, M. Sun, et al., Adv. Healthc. Mater. 6 (2017) 1700165. doi: 10.1002/adhm.201700165
111. [111]
  Q. Luo, M. Jiang, L. Kou, et al., Artif. Cells Nanomed. Biotechnol. 46 (2018) 198–208. doi: 10.1080/21691401.2017.1417864
112. [112]
  G. Wang, L. Zhao, Q. Jiang, et al., Asian J. Pharm. Sci. 15 (2020) 158–173. doi: 10.1016/j.ajps.2020.02.002
113. [113]
  L. Kou, Y. Hou, Q. Yao, et al., Artif. Cells Nanomed. Biotechnol. 46 (2018) 1605–1616.
114. [114]
  A.S. Hoffman, Acta Biomater. 40 (2016) 1–5. doi: 10.1016/j.actbio.2016.05.029
115. [115]
  V. Bourganis, T. Karamanidou, E. Samaridou, et al., Eur. J. Pharm. Biopharm. 97 (2015) 239–249. doi: 10.1016/j.ejpb.2015.01.021
116. [116]
  H. Baharifar, M. Khoobi, S.A. Bidgoli, A. Amani, Int. J. Biol. Macromol. 143 (2020) 181–189. doi: 10.1016/j.ijbiomac.2019.11.157
117. [117]
  W.S. Zhang, A. Mehta, Z.Q. Tong, L. Esser, N.H. Voelcker, Adv. Sci. 8 (2021) 2003937. doi: 10.1002/advs.202003937
118. [118]
  J.M. Rabanel, P.A. Piec, S. Landri, S.A. Patten, C. Ramassamy, J. Control. Release 328 (2020) 679–695. doi: 10.1016/j.jconrel.2020.09.042
119. [119]
  K.H. Lin, S.T. Hong, H.T. Wang, et al., Int. J. Mol. Sci. 17 (2016) 1998. doi: 10.3390/ijms17121998
120. [120]
  J. Kreuter, D. Shamenkov, V. Petrov, et al., J. Drug Target. 10 (2002) 317–325. doi: 10.1080/10611860290031877
121. [121]
  A. Taghizadehghalehjoughi, A. Hacimuftuoglu, M. Cetin, et al., Nanomedicine 13 (2018) 1595–1606. doi: 10.2217/nnm-2017-0386
122. [122]
  S. Sharma, A. Verma, G. Pandey, N. Mittapelly, P.R. Mishra, Acta Biomater. 26 (2015) 169–183. doi: 10.1016/j.actbio.2015.08.005
123. [123]
  J. Sarvaiya, Y.K. Agrawal, Int. J. Biol. Macromol. 72 (2015) 454–465. doi: 10.1016/j.ijbiomac.2014.08.052
124. [124]
  L. Wu, L. Zhao, Neural Regen. Res. 11 (2016) 412–413. doi: 10.4103/1673-5374.179044
125. [125]
  B.S. Xie, X. Wang, Y.H. Pan, et al., Theranostics 11 (2021) 1177–1191. doi: 10.7150/thno.46992
126. [126]
  F. Re, I. Cambianica, C. Zona, et al., Nanomed. Nanotechnol. 7 (2011) 551–559. doi: 10.1016/j.nano.2011.05.004
127. [127]
  D. Das, S.S. Lin, J. Pharm. Sci. 94 (2005) 1343–1353. doi: 10.1002/jps.20357
128. [128]
  M. Mehanny, R.M. Hathout, A.S. Geneidi, S. Mansour, J. Biomed. Mater. Res. A 105 (2017) 1433–1445. doi: 10.1002/jbm.a.36028
129. [129]
  P. Girotra, S.K. Singh, Pharm. Res. 33 (2016) 1682–1695. doi: 10.1007/s11095-016-1910-8
130. [130]
  K. Chatterjee, S. Sarkar, K.J. Rao, S. Paria, Adv. Colloid Interface Sci. 209 (2014) 8–39. doi: 10.1016/j.cis.2013.12.008
131. [131]
  B. Raudszus, D. Mulac, K. Langer, Int. J. Pharm. 536 (2018) 211–221. doi: 10.1016/j.ijpharm.2017.11.047
132. [132]
  R.R. de Castro, F.A. do Carmo, C. Martins, et al., Int. J. Pharm. 602 (2021) 120655. doi: 10.1016/j.ijpharm.2021.120655
133. [133]
  G. Tosi, L. Costantino, B. Ruozi, F. Forni, M.A. Vandelli, Expert Opin. Drug Deliv. 5 (2008) 155–174. doi: 10.1517/17425247.5.2.155
134. [134]
  H. Bao, X. Jin, L. Li, F. Lv, T. Liu, J. Mater. Sci. Mater. Med. 23 (2012) 1891–1901.
135. [135]
  K.R. Gajbhiye, V. Gajbhiye, I.A. Siddiqui, S. Pilla, V. Soni, Sci. Rep. 7 (2017) 11086. doi: 10.1038/s41598-017-11611-4
136. [136]
  L. Kou, Y.D. Bhutia, Q. Yao, et al., Front. Pharmacol. 9 (2018) 27. doi: 10.3389/fphar.2018.00027
137. [137]
  Y.C. Kuo, Y.C. Chen, Int. J. Pharm. 479 (2015) 138–149. doi: 10.1016/j.ijpharm.2014.12.070
138. [138]
  E. Roger, F. Lagarce, E. Garcion, J.P. Benoit, Nanomedicine 5 (2010) 287–306 Lond. doi: 10.2217/nnm.09.110
139. [139]
  K. Derakhshandeh, G. Hochhaus, S. Dadashzadeh, J Iran, Pharm. Res. 10 (2011) 425–434.
140. [140]
  P.R. Lockman, M.O. Oyewumi, J.M. Koziara, et al., J. Control. Release 93 (2003) 271–282. doi: 10.1016/j.jconrel.2003.08.006
141. [141]
  A. Kaushik, R.D. Jayant, V. Sagar, M. Nair, Expert Opin. Drug Deliv. 11 (2014) 1635–1646. doi: 10.1517/17425247.2014.933803
142. [142]
  S.A. Kulkarni, S.S. Feng, Pharm. Res. 30 (2013) 2512–2522. doi: 10.1007/s11095-012-0958-3
143. [143]
  L.M. Ensign, R. Cone, J. Hanes, Adv. Drug Deliv. Rev. 64 (2012) 557–570. doi: 10.1016/j.addr.2011.12.009
144. [144]
  E. Frohlich, Int. J. Nanomed. 7 (2012) 5577–5591.
145. [145]
  Y. Qiu, E. Rojas, R.A. Murray, et al., Nanoscale 7 (2015) 6588–6598. doi: 10.1039/C5NR00884K
146. [146]
  R.R. Arvizo, O.R. Miranda, D.F. Moyano, et al., PloS One 6 (2011) e24374. doi: 10.1371/journal.pone.0024374
147. [147]
  C. Yang, J. Uertz, D. Yohan, B.D. Chithrani, Nanoscale 6 (2014) 12026–12033. doi: 10.1039/C4NR02535K
148. [148]
  S. Behzadi, V. Serpooshan, W. Tao, et al., Chem. Soc. Rev. 46 (2017) 4218–4244. doi: 10.1039/C6CS00636A
149. [149]
  J.Z. Du, H.J. Li, J. Wang, Acc. Chem. Res. 51 (2018) 2848–2856. doi: 10.1021/acs.accounts.8b00195
150. [150]
  S. Huang, K. Shao, Y. Liu, et al., ACS Nano 7 (2013) 2860–2871. doi: 10.1021/nn400548g
151. [151]
  C.Y. Zhao, H.Z. Deng, J. Xu, et al., Nanoscale 8 (2016) 10832–10842. doi: 10.1039/C6NR02174C
1. [1]
  Linghui Zou , Meng Cheng , Kaili Hu , Jianfang Feng , Liangxing Tu . Vesicular drug delivery systems for oral absorption enhancement. Chinese Chemical Letters, 2024, 35(7): 109129-. doi: 10.1016/j.cclet.2023.109129
2. [2]
  Lei Shen , Hongmei Liu , Ming Jin , Jinchao Zhang , Caixia Yin , Shuxiang Wang , Yutao Yang . “Three-in-one” strategy of trifluoromethyl regulated blood-brain barrier permeable fluorescent probe for peroxynitrite and antiepileptic evaluation of edaravone. Chinese Chemical Letters, 2024, 35(10): 109572-. doi: 10.1016/j.cclet.2024.109572
3. [3]
  Lu Li , Suticha Chunta , Xianzi Zheng , Haisheng He , Wei Wu , Yi Lu . β-Lactoglobulin stabilized lipid nanoparticles enhance oral absorption of insulin by slowing down lipolysis. Chinese Chemical Letters, 2024, 35(4): 108662-. doi: 10.1016/j.cclet.2023.108662
4. [4]
  Xiangqian Cao , Chenkai Yang , Xiaodong Zhu , Mengxin Zhao , Yilin Yan , Zhengnan Huang , Jinming Cai , Jingming Zhuang , Shengzhou Li , Wei Li , Bing Shen . Synergistic enhancement of chemotherapy for bladder cancer by photothermal dual-sensitive nanosystem with gold nanoparticles and PNIPAM. Chinese Chemical Letters, 2024, 35(8): 109199-. doi: 10.1016/j.cclet.2023.109199
5. [5]
  Fengjie Liu , Fansu Meng , Zhenjiang Yang , Huan Wang , Yuehong Ren , Yu Cai , Xingwang Zhang . Exosome-biomimetic nanocarriers for oral drug delivery. Chinese Chemical Letters, 2024, 35(9): 109335-. doi: 10.1016/j.cclet.2023.109335
6. [6]
  Qin Yu , Haisheng He , Jianping Qi , Yi Lu , Wei Wu . Oral delivery of insulin by barbed microneedles actuated by intestinal peristalsis. Chinese Chemical Letters, 2024, 35(9): 109888-. doi: 10.1016/j.cclet.2024.109888
7. [7]
  Zhiyu Yu , Xiang Luo , Cheng Zhang , Xin Lu , Xiaohui Li , Pan Liao , Zhongqiu Liu , Rong Zhang , Shengtao Wang , Zhiqiang Yu , Guochao Liao . Mitochondria-targeted carrier-free nanoparticles based on dihydroartemisinin against hepatocellular carcinoma. Chinese Chemical Letters, 2024, 35(10): 109519-. doi: 10.1016/j.cclet.2024.109519
8. [8]
  Ke Gong , Jinghan Liao , Jiangtao Lin , Quan Wang , Zhihua Wu , Liting Wang , Jiali Zhang , Yi Dong , Yourong Duan , Jianhua Chen . Mitochondria-targeted nanoparticles overcome chemoresistance via downregulating BACH1/CD47 axis in ovarian carcinoma. Chinese Chemical Letters, 2024, 35(5): 108888-. doi: 10.1016/j.cclet.2023.108888
9. [9]
  Wenjia Wang , Xingyue He , Xiaojie Wang , Tiantian Zhao , Osamu Muraoka , Genzoh Tanabe , Weijia Xie , Tianjiao Zhou , Lei Xing , Qingri Jin , Hulin Jiang . Glutathione-depleted cyclodextrin pseudo-polyrotaxane nanoparticles for anti-inflammatory oxaliplatin (Ⅳ) prodrug delivery and enhanced colorectal cancer therapy. Chinese Chemical Letters, 2024, 35(4): 108656-. doi: 10.1016/j.cclet.2023.108656
10. [10]
  Kang Wang , Qinglin Zhou , Weijin Li . Conductive metal-organic frameworks for electromagnetic wave absorption. Chinese Journal of Structural Chemistry, 2024, 43(10): 100325-100325. doi: 10.1016/j.cjsc.2024.100325
11. [11]
  Ling Tang , Yan Wan , Yangming Lin . Lowering the kinetic barrier via enhancing electrophilicity of surface oxygen to boost acidic oxygen evolution reaction. Chinese Journal of Structural Chemistry, 2024, 43(11): 100345-100345. doi: 10.1016/j.cjsc.2024.100345
12. [12]
  Ziyi Liu , Xunying Liu , Lubing Qin , Haozheng Chen , Ruikai Li , Zhenghua Tang . Alkynyl ligand for preparing atomically precise metal nanoclusters: Structure enrichment, property regulation, and functionality enhancement. Chinese Journal of Structural Chemistry, 2024, 43(11): 100405-100405. doi: 10.1016/j.cjsc.2024.100405
13. [13]
  Tianze Wang , Junyi Ren , Dongxiang Zhang , Huan Wang , Jianjun Du , Xin-Dong Jiang , Guiling Wang . Development of functional dye with redshifted absorption based on Knoevenagel condensation at 1-site in phenyl[b]-fused BODIPY. Chinese Chemical Letters, 2024, 35(6): 108862-. doi: 10.1016/j.cclet.2023.108862
14. [14]
  Yu Yan , Jiawei Song , Dongdong Liu , Zihan Liu , Jialing Cheng , Zhiyang Chen , Yanfang Yang , Weizhe Jiang , Hongliang Wang , Jun Ye , Yuling Liu . Simple and versatile in situ thermo-sensitive hydrogel for rectal administration of SZ-A to alleviate inflammation and repair mucosal barrier in ulcerative colitis. Chinese Chemical Letters, 2024, 35(6): 109736-. doi: 10.1016/j.cclet.2024.109736
15. [15]
  Bharathi Natarajan , Palanisamy Kannan , Longhua Guo . Metallic nanoparticles for visual sensing: Design, mechanism, and application. Chinese Journal of Structural Chemistry, 2024, 43(9): 100349-100349. doi: 10.1016/j.cjsc.2024.100349
16. [16]
  Xuexia Lin , Yihui Zhou , Jiafu Hong , Xiaofeng Wei , Bin Liu , Chong-Chen Wang . Facile preparation of ZIF-8/ZIF-67-derived biomass carbon composites for highly efficient electromagnetic wave absorption. Chinese Chemical Letters, 2024, 35(9): 109835-. doi: 10.1016/j.cclet.2024.109835
17. [17]
  Zhi Li , Wenpei Li , Shaoping Jiang , Chuan Hu , Yuanyu Huang , Maxim Shevtsov , Huile Gao , Shaobo Ruan . Legumain-triggered aggregable gold nanoparticles for enhanced intratumoral retention. Chinese Chemical Letters, 2024, 35(7): 109150-. doi: 10.1016/j.cclet.2023.109150
18. [18]
  Feng Cui , Fangman Chen , Xiaochun Xie , Chenyang Guo , Kai Xiao , Ziping Wu , Yinglu Chen , Junna Lu , Feixia Ruan , Chuanxu Cheng , Chao Yang , Dan Shao . Scalable production of mesoporous titanium nanoparticles through sequential flash nanocomplexation. Chinese Chemical Letters, 2024, 35(4): 108681-. doi: 10.1016/j.cclet.2023.108681
19. [19]
  Bohan Chen , Liming Gong , Jing Feng , Mingji Jin , Liqing Chen , Zhonggao Gao , Wei Huang . Research advances of nanoparticles for CAR-T therapy in solid tumors. Chinese Chemical Letters, 2024, 35(9): 109432-. doi: 10.1016/j.cclet.2023.109432
20. [20]
  Xiangyuan Zhao , Jinjin Wang , Jinzhao Kang , Xiaomei Wang , Hong Yu , Cheng-Feng Du . Ni nanoparticles anchoring on vacuum treated Mo2TiC2Tx MXene for enhanced hydrogen evolution activity. Chinese Journal of Structural Chemistry, 2023, 42(10): 100159-100159. doi: 10.1016/j.cjsc.2023.100159

Get Citation

PDF

XML

Metrics

PDF Downloads(7)
Abstract views(376)
HTML views(15)

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142